L-HPC from Shin-Etsu is a high-quality nonionic disintegrant that is widely used in the pharmaceutical market. As an excipient, it plays a crucial role in facilitating the disintegration of tablets and capsules, ensuring rapid dissolution and efficient drug delivery. With an HPO content of 11%, L-HPC provides excellent disintegration properties, allowing for the quick release of active pharmaceutical ingredients in the body. Its particle size of 20 micrometres further enhances its effectiveness in promoting dissolution. Furthermore, L-HPC boasts a low bulk density of 0.59, making it easy to handle and incorporate into various pharmaceutical formulations. Its fine powder form allows for homogeneous blending with other excipients and active ingredients. As a nonionic disintegrant, L-HPC offers numerous advantages, including its compatibility with a wide range of drug substances and excipients. It is known for its stability and reliability, ensuring consistent performance in pharmaceutical formulations. Choose L-HPC as your disintegrant of choice for efficient drug delivery and improved patient outcomes. With its exceptional disintegration properties and ease of use, it is an essential ingredient in the development of high-quality pharmaceutical products.

Pullulan is a polysaccharide made from starch, produced by fermentation, consisting of maltotriose units. It is an excellent lubricant and adhesive with film-forming properties. It does not modify the viscosity of the final product.

Klucel™ EXF Ultra Pharm is an ultra-fine hydroxypropylcellulose (HPC) binder optimized for oral solid dosage forms in pharmaceutical applications. Delivering enhanced tablet binding efficiency, it ensures formulation predictability, reliability, and robustness. With superior flow properties and broad compatibility, it supports high-performance drug delivery solutions, making it a preferred choice for pharmaceutical manufacturers.

METOLOSE® SR 90SH-15000SR provides a genuine consistency in Sustained release (matrix tablets). It can be used for semi solid drug products. For Hydrophilic matrix formulation of API and METOLOSE® SR to extend the dissolution. The dosage forms can be obtained by direct compression or granulation process. METOLOSE® SR has specifications of particle size which can be suitable for sustained release application. Dissolution profile can be easily adjusted by selecting appropriate grade. Recommendable amount of METOLOSE® SR is more than 20% in the formulation in order to form the stable gel layer.